Evidence map›Paper›PMID 34523805›Full record

ArticleInternational journal of laboratory hematology2021

Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID-19.

Yuki Horiuchi, Fumiaki Hayashi, Yosuke Iwasaki, Akihiko Matsuzaki, Kumiko Nishibe, Kimiko Kaniyu, Setsuko Marutani, Kaori Saito, Sachiko Matsuoka, Kinya Uchihashi and 3 more

Abstract readComparative Study
In one paragraph

Article in International journal of laboratory hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yuki HoriuchiDepartment of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.ORCID https://orcid.org/0000-0003-2191-5405
Fumiaki HayashiScientific Affairs, Sysmex Corporation, Kobe, Japan.
Yosuke IwasakiScientific Affairs, Sysmex Corporation, Kobe, Japan.
Akihiko MatsuzakiDepartment of Next Generation Haematology Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.
Kumiko NishibeDepartment of Next Generation Haematology Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.
Kimiko KaniyuDepartment of Next Generation Haematology Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.
Setsuko MarutaniDepartment of Next Generation Haematology Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.
Kaori SaitoDepartment of Next Generation Haematology Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.
Sachiko MatsuokaDepartment of Next Generation Haematology Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.
Kinya UchihashiSysmex Corporation, Kobe, Japan.
Takashi MiidaDepartment of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.
Tomohiko AiDepartment of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.ORCID https://orcid.org/0000-0003-0376-0227
Yoko TabeDepartment of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.

Funding

Grants-in Aid for Scientific Research 18K07424 to YTInternational Joint Research Programs 19KK0221toYT
6 · The paper itself

Abstract

introductionDeveloping prognostic markers can be useful for clinical decision-making. Peripheral blood (PB) examination is simple and basic that can be performed in any facility. We aimed to investigate whether PB examination can predict prognosis in coronavirus disease (COVID-19).

methodsComplete blood count (CBC) and PB cell morphology were examined in 38 healthy controls (HCs) and 40 patients with COVID-19. Patients with COVID-19, including 26 mild and 14 severe cases, were hospitalized in Juntendo University Hospital (Tokyo, Japan) between April 1 and August 6, 2020. PB examinations were performed using Sysmex XN-3000 automated hematology analyzer and Sysmex DI-60 employing the convolutional neural network-based automatic image-recognition system.

resultsCompared with mild cases, severe cases showed a significantly higher incidence of anemia, lymphopenia, and leukocytosis (P < .001). Granular lymphocyte counts were normal or higher in mild cases and persistently decreased in fatal cases. Temporary increase in granular lymphocytes was associated with survival of patients with severe infection. Red cell distribution width was significantly higher in severe cases than in mild cases (P < .001). Neutrophil dysplasia was consistently observed in COVID-19 cases, but not in HCs. Levels of giant neutrophils and toxic granulation/Döhle bodies were increased in severe cases.

conclusionBasic PB examination can be useful to predict the prognosis of COVID-19, by detecting SARS-CoV-2 infection-induced multi-lineage changes in blood cell counts and morphological anomalies. These changes were dynamically correlated with disease severity and may be associated with disruption of hematopoiesis and the immunological system due to bone marrow stress in severe infection.

Indexed as

Blood Cell CountSARS-CoV-2AgedAnemiaCell ShapeCOVID-19Cytoplasmic GranulesErythrocyte IndicesFemaleHumansImage Processing, Computer-AssistedLeukocytosisLymphocyte CountLymphocytesLymphopeniaMaleblood cell countsCOVID-19granular lymphocytesmorphological anomaliesperipheral blood

Identifiers

PMID34523805
PMCPMC8653062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.